Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Three highly immunogenic peptides from gluten are primarily responsible for celiac disease, suggesting a rational immunotherapeutic approach that could replace the need for strict, lifelong dietary gluten avoidance.

More information

DOI

10.1126/scitranslmed.3001012

Type

Journal article

Publisher

American Association for the Advancement of Science (AAAS)

Publication Date

21/07/2010

Volume

2